Selected article for: "cellular injury and hepatitis virus"

Author: Levy, G.; Abecassis, M.
Title: Activation of the Immune Coagulation System by Murine Hepatitis Virus Strain 3
  • Cord-id: ixmjex6t
  • Document date: 1989_5_25
  • ID: ixmjex6t
    Snippet: Viral infections result in alterations in hemostasis and coagulation. It has previously been shown that susceptibility to murine hepatitis virus strain 3 (MHV-3), a coronavirus, correlates directly with the spontaneous, T lymphocyte-instructed expression of a procoagulant monokine that exhibits prothrombin-cleaving activity (procoagulant activity [PCA]). A biologic role for PCA in the pathogenesis of MHV-3 infection is suggested by results of in vivo microscopic observations made during acute MH
    Document: Viral infections result in alterations in hemostasis and coagulation. It has previously been shown that susceptibility to murine hepatitis virus strain 3 (MHV-3), a coronavirus, correlates directly with the spontaneous, T lymphocyte-instructed expression of a procoagulant monokine that exhibits prothrombin-cleaving activity (procoagulant activity [PCA]). A biologic role for PCA in the pathogenesis of MHV-3 infection is suggested by results of in vivo microscopic observations made during acute MHV-3 infection. Recently, it has been demonstrated that prostaglandin E2 abrogates the induction of PCA by MHV-3 both in vivo and in vitro and prevents hepatic necrosis and the associated microcirculatory changes. These data suggest that MHV-3 induces cellular injury through the activation of the coagulation cascade and provide further evidence for a role for PCA in the pathogenesis of MHV-3 infection.

    Search related documents:
    Co phrase search for related documents
    • acid metabolism and acute phase: 1
    • acid metabolism and liver disease: 1, 2, 3, 4, 5
    • acid metabolism and liver disease develop: 1
    • acid metabolism and liver injury: 1, 2, 3
    • acute disease and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute disease and liver damage evidence: 1
    • acute disease and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver disease develop: 1
    • acute disease and liver inflammatory disease: 1, 2
    • acute disease and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and local coagulation: 1, 2
    • acute phase and liver blood flow: 1
    • acute phase and liver damage: 1, 2, 3, 4, 5, 6
    • acute phase and liver disease: 1, 2, 3, 4, 5, 6
    • acute phase and liver disease develop: 1
    • acute phase and liver injury: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and local coagulation: 1
    • liver injury and local coagulation: 1